XPONANCE, INC. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q1 2022$158,000
-48.4%
11,412
+4.8%
0.00%
-40.0%
Q4 2021$306,000
-18.2%
10,894
-1.1%
0.01%
-28.6%
Q3 2021$374,000
-18.2%
11,016
-1.6%
0.01%
-12.5%
Q2 2021$457,000
+38.9%
11,193
+37.0%
0.01%
+14.3%
Q1 2021$329,000
-28.5%
8,168
+5.0%
0.01%
-30.0%
Q4 2020$460,000
+18.6%
7,778
-2.4%
0.01%0.0%
Q3 2020$388,000
+7.2%
7,971
+6.6%
0.01%
+11.1%
Q2 2020$362,0007,4740.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2021
NameSharesValueWeighting ↓
Matrix Capital Management Company, LP 15,115,090$419,897,00010.74%
TIGER MANAGEMENT L.L.C. 1,115,411$30,986,00010.41%
Robertson Stephens Wealth Management, LLC 537,095$14,920,0005.10%
VIKING GLOBAL INVESTORS LP 33,493,708$930,455,0004.84%
Senator Investment Group LP 3,388,085$94,121,0003.41%
Casdin Capital, LLC 793,125$22,033,0002.34%
Iron Triangle Partners LP 150,000$4,167,0001.61%
Aristotle Atlantic Partners, LLC 370,841$10,302,0001.57%
Crewe Advisors LLC 93,000$2,584,0001.54%
PERSONAL CFO SOLUTIONS, LLC 112,916$3,137,0001.13%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders